Cargando…
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs fro...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308918/ https://www.ncbi.nlm.nih.gov/pubmed/25723320 http://dx.doi.org/10.1186/s13059-014-0568-y |
_version_ | 1782354609546723328 |
---|---|
author | Lim, Emilia L Trinh, Diane L Scott, David W Chu, Andy Krzywinski, Martin Zhao, Yongjun Robertson, A Gordon Mungall, Andrew J Schein, Jacqueline Boyle, Merrill Mottok, Anja Ennishi, Daisuke Johnson, Nathalie A Steidl, Christian Connors, Joseph M Morin, Ryan D Gascoyne, Randy D Marra, Marco A |
author_facet | Lim, Emilia L Trinh, Diane L Scott, David W Chu, Andy Krzywinski, Martin Zhao, Yongjun Robertson, A Gordon Mungall, Andrew J Schein, Jacqueline Boyle, Merrill Mottok, Anja Ennishi, Daisuke Johnson, Nathalie A Steidl, Christian Connors, Joseph M Morin, Ryan D Gascoyne, Randy D Marra, Marco A |
author_sort | Lim, Emilia L |
collection | PubMed |
description | BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs from 92 DLBCL and 15 benign centroblast fresh frozen samples and from 140 DLBCL formalin-fixed, paraffin-embedded tissue samples for validation. RESULTS: We identify known and candidate novel miRNAs, 25 of which are associated with survival independently of cell-of-origin and International Prognostic Index scores, which are established indicators of outcome. Of these 25 miRNAs, six miRNAs are significantly associated with survival in our validation cohort. Abundant expression of miR-28-5p, miR-214-5p, miR-339-3p, and miR-5586-5p is associated with superior outcome, while abundant expression of miR-324-5p and NOVELM00203M is associated with inferior outcome. Comparison of DLBCL miRNA-seq expression profiles with those from other cancer types identifies miRNAs that were more abundant in B-cell contexts. Unsupervised clustering of miRNAs identifies two clusters of patients that have distinct differences in their outcomes. Our integrative miRNA and mRNA expression analyses reveal that miRNAs increased in abundance in DLBCL appear to regulate the expression of genes involved in metabolism, cell cycle, and protein modification. Additionally, these miRNAs, including one candidate novel miRNA, miR-10393-3p, appear to target chromatin modification genes that are frequent targets of somatic mutation in non-Hodgkin lymphomas. CONCLUSIONS: Our comprehensive sequence analysis of the DLBCL miRNome identifies candidate novel miRNAs and miRNAs associated with survival, reinforces results from previous mutational analyses, and reveals regulatory networks of significance for lymphomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0568-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4308918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43089182015-01-29 Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients Lim, Emilia L Trinh, Diane L Scott, David W Chu, Andy Krzywinski, Martin Zhao, Yongjun Robertson, A Gordon Mungall, Andrew J Schein, Jacqueline Boyle, Merrill Mottok, Anja Ennishi, Daisuke Johnson, Nathalie A Steidl, Christian Connors, Joseph M Morin, Ryan D Gascoyne, Randy D Marra, Marco A Genome Biol Research BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs from 92 DLBCL and 15 benign centroblast fresh frozen samples and from 140 DLBCL formalin-fixed, paraffin-embedded tissue samples for validation. RESULTS: We identify known and candidate novel miRNAs, 25 of which are associated with survival independently of cell-of-origin and International Prognostic Index scores, which are established indicators of outcome. Of these 25 miRNAs, six miRNAs are significantly associated with survival in our validation cohort. Abundant expression of miR-28-5p, miR-214-5p, miR-339-3p, and miR-5586-5p is associated with superior outcome, while abundant expression of miR-324-5p and NOVELM00203M is associated with inferior outcome. Comparison of DLBCL miRNA-seq expression profiles with those from other cancer types identifies miRNAs that were more abundant in B-cell contexts. Unsupervised clustering of miRNAs identifies two clusters of patients that have distinct differences in their outcomes. Our integrative miRNA and mRNA expression analyses reveal that miRNAs increased in abundance in DLBCL appear to regulate the expression of genes involved in metabolism, cell cycle, and protein modification. Additionally, these miRNAs, including one candidate novel miRNA, miR-10393-3p, appear to target chromatin modification genes that are frequent targets of somatic mutation in non-Hodgkin lymphomas. CONCLUSIONS: Our comprehensive sequence analysis of the DLBCL miRNome identifies candidate novel miRNAs and miRNAs associated with survival, reinforces results from previous mutational analyses, and reveals regulatory networks of significance for lymphomagenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0568-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-29 2015 /pmc/articles/PMC4308918/ /pubmed/25723320 http://dx.doi.org/10.1186/s13059-014-0568-y Text en © Lim et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lim, Emilia L Trinh, Diane L Scott, David W Chu, Andy Krzywinski, Martin Zhao, Yongjun Robertson, A Gordon Mungall, Andrew J Schein, Jacqueline Boyle, Merrill Mottok, Anja Ennishi, Daisuke Johnson, Nathalie A Steidl, Christian Connors, Joseph M Morin, Ryan D Gascoyne, Randy D Marra, Marco A Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title_full | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title_fullStr | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title_full_unstemmed | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title_short | Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients |
title_sort | comprehensive mirna sequence analysis reveals survival differences in diffuse large b-cell lymphoma patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308918/ https://www.ncbi.nlm.nih.gov/pubmed/25723320 http://dx.doi.org/10.1186/s13059-014-0568-y |
work_keys_str_mv | AT limemilial comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT trinhdianel comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT scottdavidw comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT chuandy comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT krzywinskimartin comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT zhaoyongjun comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT robertsonagordon comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT mungallandrewj comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT scheinjacqueline comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT boylemerrill comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT mottokanja comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT ennishidaisuke comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT johnsonnathaliea comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT steidlchristian comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT connorsjosephm comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT morinryand comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT gascoynerandyd comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients AT marramarcoa comprehensivemirnasequenceanalysisrevealssurvivaldifferencesindiffuselargebcelllymphomapatients |